Veeva Systems Inc is a leading provider of cloud-based software solutions tailored specifically for the global life sciences industry
The company offers a range of products designed to streamline and enhance various aspects of the pharmaceutical and biotech sectors, including research and development, regulatory compliance, and commercial operations. By leveraging advanced technology and data analytics, Veeva enables life sciences organizations to improve their efficiency, accelerate drug development processes, and ensure adherence to regulatory standards, ultimately contributing to better patient outcomes and innovation in healthcare.
Shares of healthcare software provider Veeva Systems (NASDAQVEEV)
jumped 9.9% in the afternoon session after the company reported impressive fourth quarter (fiscal 2025) results which beat analysts' revenue and adjusted operating profit expectations. Notably, subscription services revenue, making up the bulk of total revenue, rose 17% year over year. This growth was driven by expanding adoption of Veeva's cloud-based solutions across both R&D and commercial segments, reflecting continued demand from life sciences companies.
Looking ahead, while full-year revenue guidance was just in line with Wall Street's estimates, full-year operating profit guidance was above. Overall, this was a solid quarter.
Healthcare software provider Veeva Systems (NASDAQVEEV) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.3% year on year to $720.9 million. The company expects next quarter’s revenue to be around $727.5 million, close to analysts’ estimates. Its non-GAAP profit of $1.74 per share was 10.1% above analysts’ consensus estimates.
U.S. stock futures fell on Thursday following Wednesday’s relief after a two-day fall. Futures of all four benchmark indices fell in premarket trading. President Donald Trump’s administration postponed implementation of auto tariffs by one month on Wednesday after the tariffs on Canada, Mexico, and China were implemented on Tuesday.
NYSE:VEEV is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.
Based on fundamental and technical analysis of NYSE:VEEV we conclude: VEEVA SYSTEMS INC-CLASS A (NYSEVEEV): a strong growth stock preparing for the next leg up?.
VEEVA SYSTEMS INC-CLASS A was identified as a growth stock that isn't overvalued. NYSE:VEEV is excelling in various growth indicators while maintaining a solid financial footing.
Veeva's strong remote work policies are attracting top talent and boosting stock performance, contrasting with JPMorgan's return-to-office mandate amid employee backlash.
What has Wall Street been buzzing about this week? Here is a brief look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Jan. 20-24, 2025.
